Cell-free DNA in the supernatant of pleural effusion as bio-source for diagnostic biomarker tests 221 6 References 1. Li, T., Kung, H.J., Mack, P.C., Gandara, D.R. Genotyping and genomic profiling of non-smallcell lung cancer: implications for current and future therapies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013;31(8):1039-49. 2. Cross, D.A. et al. AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer discovery. 2014;4(9):1046-61. 3. Froudarakis, M.E. Pleural effusion in lung cancer: more questions than answers. Respiration. 2012;83(5):367-76. 4. Liu, D. et al. Malignant pleural effusion supernatants are substitutes for metastatic pleural tumor tissues in EGFR mutation test in patients with advanced lung adenocarcinoma. PloS one. 2014;9(2):e89946. 5. Lin, J., Gu, Y., Du, R., Deng, M., Lu, Y., Ding, Y. Detection of EGFR mutation in supernatant, cell pellets of pleural effusion and tumor tissues from non-small cell lung cancer patients by high resolution melting analysis and sequencing. International journal of clinical and experimental pathology. 2014;7(12):8813-22. 6. Asaka, S. et al. Rapid point-of-care testing for epidermal growth factor receptor gene mutations in patients with lung cancer using cell-free DNA from cytology specimen supernatants. International Journal of Oncology. 2018;52(6):2110-2118 7. Kawahara, A. et al. A combined test using both cell sediment and supernatant cell-free DNA in pleural effusion shows increased sensitivity in detecting activating EGFR mutation in lung cancer patients. Cytopathology. 2018;29(2):150-155 8. Shin, S., Kim,J ., Kim, Y., Cho, S.M., Lee, K.A. Assessment of real-time PCR method for detection of EGFR mutation using both supernatant and cell pellet of malignant pleural effusion samples from non-small-cell lung cancer patients. Clin Chem Lab Med. 2017;55(12):1962-1969 9. Lee, J.S., et al. Liquid biopsy using the supernatant of a pleural effusion for EGFR genotyping in pulmonary adenocarcinoma patients: a comparison between cell-free DNA and extracellular vesicle-derived DNA. BMC Cancer. 2018;18(1):1236. 10. Yung, T.K., Chan, K.C., Mok, T.S., Tong, J., To, K.F., Lo, Y.M. Single-molecule detection of epidermal growth factor receptor mutations in plasma by microfluidics digital PCR in non-small cell lung cancer patients. Clin Cancer Res. 2009;15(6):2076-84. 11. Oxnard, G.R, et al. Association between plasma genotyping and outcomes of treatment with Osimertinib (AZD9291) in advanced Non-Small-Cell Lunc Cancer. Journal of Clinical Oncology. 2016;334(28):3375-82.
RkJQdWJsaXNoZXIy MTk4NDMw